abstract |
The use of a compound of formula (A): OR a bioprecursor, or a pharmaceutically acceptable phosphate ester and / or acyl derivative salt of any of the foregoing in the manufacture of a medicament for use in treatment (including prophylaxis) of HHV-8 infection. |